300147 Xiangxue Pharmaceutical
- 7.17
- +0.44+6.54%
Xiangxue Pharmaceutical News
Xiangxue Pharmaceutical: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders
Xiangxue Pharmaceutical: Announcement of Resolutions of the 2024 First Extraordinary General Meeting of Shareholders
Xiangxue Pharmaceutical: Notice on Convening the First Extraordinary General Meeting of Shareholders in 2024
Xiangxue Pharmaceuticals: Board of Directors Rules of Procedure
Xiangxue Pharmaceutical: Announcement on Adjusting the Audit Committee Members of the Board of Directors
Xiangxue Pharmaceutical: Summary table on the use of non-operating capital and other related capital transactions for the first half year of 2024
Xiangxue Pharmaceutical: Comparative Table of Amendments to the Articles of Association
Xiangxue Pharmaceutical: Announcement Regarding Resignation of Securities Affairs Representative
Xiangxue Pharmaceutical: Announcement regarding the inclusion of TAEST16001 injection into the list of breakthrough therapy.
Xiangxue Pharmaceutical: Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Xiangxue Pharmaceutical: Legal opinion on the 2023 annual general meeting of shareholders.
Xiangxue Pharmaceutical: Notice on the progress of major litigation cases
Xiangxue Pharmaceutical: Notice on convening the 2023 Annual General Meeting of Shareholders
Xiangxue Pharmaceutical: Comparative table of amendments to the company's articles of association
Xiangxue Pharmaceutical: Announcement on re-election of directors, re-appointment of senior management personnel and securities affairs representatives
Xiangxue Pharmaceutical: Rules of work of the Nomination Committee of the Board
Xiangxue Pharmaceutical: Rules of work for special meetings of independent directors
Xiangxue Pharmaceutical: Rules of work of the Board of Directors Audit Committee
Xiangxue Pharmaceutical: Board Secretary Work Rules
Xiangxue Pharmaceutical: Board of Directors Rules of Procedure
Analysis
Price Target
No Data
No Data